Implementation of PrEP for Women Who Inject Drugs Through Practice Facilitation in Primary and Reproductive Health Care
Women who inject drugs are among the most vulnerable to acquiring HIV, but very few women who inject drugs are prescribed pre-exposure prophylaxis (PrEP) for HIV prevention largely due to barriers within our healthcare system. This research will consider the perspectives of women who inject drugs, healthcare providers, and clinic leadership to improve the way primary care and reproductive health clinics deliver PrEP to women who inject drugs, thereby reducing new HIV infections in this population.
⁃ To be included in the pilot test of Practice Facilitation, clinics must:
• Complete prior leadership and provider surveys
• Have 50 or more clinic visits with women who inject drugs in the past year
• Have 3 or more clinicians who provide primary and/or reproductive healthcare
• Have leadership willing to participate